Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Robarts Research Institute, |
RCV000408877 | SCV000484831 | uncertain significance | Hypercholesterolemia, familial, 1 | criteria provided, single submitter | clinical testing | ||
Laboratory of Genetics and Molecular Cardiology, |
RCV000408877 | SCV000588449 | uncertain significance | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV001837890 | SCV000777031 | benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV001256895 | SCV001433396 | likely benign | not specified | 2020-01-23 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV003477905 | SCV002046104 | benign | not provided | 2022-08-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002411273 | SCV002722262 | likely benign | Cardiovascular phenotype | 2018-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
GENin |
RCV004584701 | SCV005074033 | benign | Familial hypercholesterolemia | 2023-11-06 | criteria provided, single submitter | clinical testing |